These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10481790)

  • 1. Effect of niravoline (RU51599), a kappa-opioid receptor agonist, on tumour-origin brain oedema.
    Takahashi H; Hamada H; Teramoto A
    Acta Neurochir (Wien); 1999; 141(7):771-8. PubMed ID: 10481790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema.
    Takahashi H; Hamada H; Teramoto A
    Acta Neurochir Suppl; 2000; 76():323-7. PubMed ID: 11450035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599.
    Ikeda Y; Teramoto A; Nakagawa Y; Ishibashi Y; Yoshii T
    Acta Neurochir (Wien); 1997; 139(12):1173-9; discussion 1179-80. PubMed ID: 9479425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin release inhibitor RU51599 attenuates brain oedema following transient forebrain ischaemia in rats.
    Ikeda Y; Toda S; Kawamoto T; Teramoto A
    Acta Neurochir (Wien); 1997; 139(12):1166-71; discussion 1171-2. PubMed ID: 9479424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.
    Gadano A; Moreau R; Pessione F; Trombino C; Giuily N; Sinnassamy P; Valla D; Lebrec D
    J Hepatol; 2000 Jan; 32(1):38-42. PubMed ID: 10673065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis.
    Moreau R; Cailmail S; Hamon G; Lebrec D
    J Gastroenterol Hepatol; 1996 Sep; 11(9):857-63. PubMed ID: 8889966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion.
    Bemana I; Nagao S
    J Neurotrauma; 1998 Feb; 15(2):117-24. PubMed ID: 9512087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niravoline, a selective kappa-opioid receptor agonist effectively reduces elevated intracranial pressure.
    Nagao S; Bemana I; Kuratani H; Takahashi E; Nakamura T
    Exp Brain Res; 2000 Feb; 130(3):338-44. PubMed ID: 10706433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke.
    Guéniau C; Oberlander C
    J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human lipocortin I on brain oedema in a rat glioma model.
    Chang CC; Shinonaga M; Kuwabara T; Mima T; Shigeno T
    Acta Neurochir Suppl (Wien); 1990; 51():145-7. PubMed ID: 2151008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
    Bellissant E; Denolle T; Sinnassamy P; Bichet DG; Giudicelli JF; Lecoz F; Gandon JM; Allain H
    J Pharmacol Exp Ther; 1996 Jul; 278(1):232-42. PubMed ID: 8764356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of arginine vasopressin (AVP) inhibitor in the inhibition of the peritumoral edema].
    Hamada H; Takahashi H; Teramoto A; Yoshii T
    No To Shinkei; 1997 Nov; 49(11):1001-6. PubMed ID: 9396031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen free radicals in the genesis of peritumoural brain oedema in experimental malignant brain tumours.
    Ikeda Y; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():142-4. PubMed ID: 1965270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter amines in brain edema of a rat glioma model.
    Chang CC
    Neurol Med Chir (Tokyo); 1989 Mar; 29(3):187-91. PubMed ID: 2477722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB; Thompson AC; Shippenberg T
    Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid therapy of experimental tumour oedema.
    Matsuoka Y; Hossmann KA
    Neurosurg Rev; 1981; 4(4):185-90. PubMed ID: 7329560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density.
    D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
    J Mol Neurosci; 2004; 24(2):307-14. PubMed ID: 15456944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.